Lilly to acquire gene therapy specialist, Prevail Therapeutics, in a deal worth US$1.04bn

Lilly to acquire gene therapy specialist, Prevail Therapeutics, in a deal worth US$1.04bn

Submitted by admin on December 15, 2020 - 10:57am
Source: 
Biopharma Reporter
News Tags: 
Eli Lilly
Prevail Therapeutics
M&A
Headline: 
Lilly to acquire gene therapy specialist, Prevail Therapeutics, in a deal worth US$1.04bn
snippet: 

US pharma giant, Eli Lilly and Co, announced today that it would buy Prevail Therapeutics Inc in a deal valued at US$1.04bn.

Do Not Allow Advertisers to Use My Personal information